
The scrip has climbed 22.43 per cent in the last one year till date, while the 30-share index has gained 56.24 per cent during the same period.
Did you Know?
Stock score of Aurobindo Pharma Ltd moved down by 1 in a week.
View Latest Stock Report »Trading volume on the counter stood at 41,391 shares, while it quoted a price-to-earnings ratio of 10.57, an EPS value of 91.05 and a price-to-book value of 1.44. In the Nifty50 pack, 38 stocks traded in the green, while 12 stocks were in the red.
Promoter/FII Holding
Promoters held 51.94 per cent stake in the company as of 31-Mar-2021, while foreign institutional investors and mutual funds' ownership stood at 26.62 per cent and 8.84 per cent, respectively.
For the quarter ended 31-Mar-2021, the company reported consolidated sales of Rs 6079.6 crore, down 6.44 per cent from the previous quarter's Rs 6498.31 crore and down 1.8 per cent from the year-ago quarter's Rs 6191.02 crore. The company reported net profit of Rs 801.58 crore for the latest quarter.
Technical Indicators
The MACD signalled a bearish bias on the counter. The MACD is known for signalling trend reversals in traded securities or indices. It is the difference between the 26-day and 12-day exponential moving averages. A nine-day exponential moving average, called the signal line, is plotted on top of the MACD to reflect "buy" or "sell" opportunities. When the MACD crosses below the signal line, it gives a bearish signal, indicating that the price of the security may see a downward movement and vice versa.
Download The Economic Times News App to get Daily Market Updates & Live Business News.